Abstract
The role of surgery for patients with stage IIIA-N2 non-small-cell lung cancer (NSCLC) who have persistent nodal disease after induction chemotherapy or induction chemoradiation is unclear. The objective of this study is to evaluate the long-term survival of patients with Stage IIIA-N2 NSCLC who undergo surgery for persistent N1 or N2 disease following induction therapy.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
